Ehp-101 (VCE-004.8) is an orally effective, specific PPARgamma and CB2 receptor dual agonist. HP-101 inhibits prolyl - hydroxylase (PHDs) and activates the HIF pathway. HP-101 is a semi-synthetic, multi-target cannabinoid with potent anti-inflammatory activi
Molecular Weight:
433.58
Purity:
>99%
CAS Number:
[1818428-24-8]
Formula:
C28H35NO3
Target:
PPAR
* VAT and and shipping costs not included. Errors and price changes excepted